Group 1 - The global IPO market showed significant recovery in 2025, with Hong Kong Stock Exchange returning to the top position globally, hosting 114 IPOs and raising 286.3 billion HKD [1][2] - The largest IPO globally was Medline, which raised approximately 62 billion USD on NASDAQ, surpassing the Indian National Stock Exchange, which ranked second with 268 listings and a total fundraising of 1.78 trillion INR [2][4] - The top ten IPOs in 2025 were diverse in industry, including sectors such as biomedicine, security, and finance, with Hong Kong Stock Exchange accounting for four of these IPOs [3][6] Group 2 - Medline's IPO on December 17, 2025, marked a significant milestone, with a first-day market valuation exceeding 54 billion USD, providing substantial returns to its private equity backers [4][5] - Verisure, a Swedish security company, also had a notable IPO, raising approximately 36 billion EUR and achieving a first-day increase of 21%, marking it as the largest IPO in Europe since 2022 [4][5] - Predictions for 2026 indicate a potential wave of large IPOs, particularly from major US exchanges, with estimates of 200 to 230 companies going public and raising between 40 to 60 billion USD [7][8] Group 3 - Hong Kong is expected to maintain competitiveness in the IPO market, with forecasts suggesting around 150 new listings in 2026, raising between 320 to 350 billion HKD, driven by technology, consumer, and green economy sectors [8] - The competition between US and Hong Kong capital markets is anticipated to intensify, with both markets expected to see significant IPO activity [8]

Core Insights - Verisure, a leading security company in Europe, went public on October 8, 2023, with a market capitalization of €16.5 billion (approximately ¥136 billion), marking the largest IPO in Europe since 2022 and a significant exit for the private equity (PE) industry [3][5][10] - The company has demonstrated remarkable growth, with its valuation increasing by over €15 billion in 17 years, from €0.9 billion at the time of EQT's acquisition in 2008 to its current valuation [3][12] - Verisure's unique business model focuses on subscription services rather than hardware sales, resulting in a stable cash flow and high profitability, with an EBITDA margin of 45% and a gross margin of 75% [7][10] Business Model and Financial Performance - Verisure generates approximately €3 billion in annual subscription revenue from its 5.8 million customers, with an average subscription fee exceeding €500 per user per year [10][11] - The company has a low customer churn rate of 7.4%, with an average customer lifespan of 15 years, contributing to predictable cash flows [10][11] - In 2024, Verisure reported total revenue of €3.4 billion and an adjusted EBITDA of €1.5 billion, showcasing its strong financial performance [7][10] Historical Growth and Private Equity Involvement - Verisure was initially part of Securitas AB and became a standalone entity in 2006. It was acquired by EQT in 2008 for SEK 10.1 billion (approximately €0.9 billion) [12][13] - Under EQT's management, Verisure focused on operational improvements, leading to a doubling of its EBITDA over four years [13][14] - Subsequent ownership by Bain Capital and Hellman & Friedman (H&F) saw Verisure expand internationally, increasing its user base from 1.4 million in 2011 to 4 million by 2021 [14][18] Market Position and Competitive Advantage - Verisure holds a 25% market share in the European home security market, significantly outpacing its nearest competitor [18] - The company's emphasis on providing comprehensive, high-quality monitoring services differentiates it from competitors that primarily sell hardware [10][18] - Verisure's strategic acquisitions, such as the purchase of Arlo's European business, have enhanced its technological capabilities and market position [18] Future Outlook - The current valuation of Verisure may still be below H&F's expectations, as the company was valued at $17 billion in 2020 [21] - The stability of Verisure's cash flow allows for the potential use of higher leverage in future acquisitions, which could further enhance its growth prospects [19][21] - The success of Verisure serves as a benchmark for private equity investments, demonstrating the power of patient capital in achieving compounded growth over time [20]